(Q45413785)

English

Effects of monotherapy with (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) on the evolution of a primary Simian immunodeficiency virus (SIV) isolate.

scientific article published in August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Effects of monotherapy with (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) on the evolution of a primary Simian immunodeficiency virus (SIV) isolate (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Simian immunodeficiency virus

object named as

Simian immunodeficiency virus

1 reference

based on heuristic

inferred from title

Deborah H Fuller

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Rachel Taber

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Premeela A Rajakumar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Anita M Trichel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Patricia Dowling

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

David Meleason

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Angela Amedee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Michael Murphey-Corb

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

354

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

116-131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16884757%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Different evolution of simian immunodeficiency virus in a natural host and a new host

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Rapid molecular epidemiology of human immunodeficiency virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

SIVsm quasispecies adaptation to a new simian host

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251...

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Effects of initiation of 3'-azido,3'-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Genetic analysis of simian immunodeficiency virus expressed in milk and selectively transmitted through breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.06.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45413785&oldid=1609594562"